Neukio
1 known investors
Neukio is a biopharmaceutical company developing iPSC-derived cell technology platforms and next-generation off-the-shelf, mass-producible immune cell products (such as NK cells) to treat solid tumors and autoimmune diseases. It focuses on innovation in both product and process development to lower cell therapy production costs and expand indication coverage.
Founders & leadership
LW
Liqun WangFounder
Investors · 1
Frequently asked questions
- What does Neukio do?
- Neukio is a biopharmaceutical company developing iPSC-derived cell technology platforms and next-generation off-the-shelf, mass-producible immune cell products (such as NK cells) to treat solid tumors and autoimmune diseases. It focuses on innovation in both product and process development to lower cell therapy production costs and expand indication coverage.
- Who founded Neukio?
- Neukio was founded by Liqun Wang.
- Who are Neukio's investors?
- Neukio's investors include Pan-Lin Capital.